mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |